FDA

On May 15, 2013, the U.S. Food and Drug Administration approved radium Ra 223 dichloride (Xofigo Injection, Bayer HealthCare Pharmaceuticals Inc.) for...

[Read the rest of this article...]

 Posted in: FDA
On May 14, 2013, the U. S. Food and Drug Administration approved erlotinib (Tarceva®, Astellas Pharma Inc.) for the first-line treatment of metast...

[Read the rest of this article...]

 Posted in: Clinical Trials, FDA
ASCO, along with the American Association for Cancer Research, the Association of American Cancer Institutes and Friends of Cancer Research, is holding an advocacy day on Capitol Hill this week to advocate for sustained funding for the National Institutes of Health and the Food and Drug Administration.

[Read the rest of this article...]

In written testimony to Congress on April 26, ASCO President Sandra M. Swain, MD, FACP, urged legislators to support a “strong federal investmen...

[Read the rest of this article...]

The following profile of ASCO’s Cancer Research Committee is the second in a series of articles to help ASCO members better understand the role that volunteers serve and the critical work in which committee members are engaged.

[Read the rest of this article...]

 Posted in: Clinical Trials, FDA, NCI
ASCO and more than 150 other national organizations and institutions are supporting The Rally for Medical Research, on April 8 in Washington, D.C. The event will call on policymakers to make life-saving medical research funding a national priority.

[Read the rest of this article...]

The House today passed a stopgap federal spending bill, now on its way to the White House for signing, to prevent a government shutdown next week. The measure includes an additional $71 million for the National Institutes of Health as well as an additional $10 million for the National Cancer Institute. It also includes an additional $74 million for the Food and Drug Administration.

[Read the rest of this article...]

ASCO President Sandra M. Swain, MD, FACP, called for a strong federal investment in the U.S. Food and Drug Administration for fiscal year 2014.

[Read the rest of this article...]

Page 1 of 11First   Previous   [1]  2  3  4  5  6  7  8  9  10  Next   Last   

 

ASCO

 


Grassroots Action Center/ACT Network




Categories